Treatment of Pruritus With Intramuscular Promethazine

NCT04805073 — Phase 4, Completed, 72 participants, University of Florida

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Assessing Efficacy of Intramuscular Promethazine for the Treatment of Intrathecal Morphine Induced Pruritus

RegistryNCT04805073
StatusCompleted
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: triple, treatment
Enrollment72 (Actual)
SponsorUniversity of Florida (Other)
ConditionsPruritus, Pregnancy Related
InterventionsPromethazine, Placebo (Drug)
Datesstart 2021-08-09, primary completion 2024-05-30, completion 2024-05-30, first posted 2021-03-18, last updated 2025-05-04
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Pruritus All trials for Pregnancy Related All trials of Promethazine All trials of Placebo

-Summary

Neuraxial narcotics are commonly used in obstetric patients for cesarean delivery to help with pain control over the first 24 hours after the surgery. The aim is to evaluate effectiveness of promethazine (IMP) treatment of intrathecal morphine induced pruritus (ITIMIP). A treatment for ITMIP, other than naloxone, will allow for increased use of intrathecal narcotics and decrease the use of systemic opioids in the initial post-operative period.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
PromethazineExperimentalDrug: PromethazineThe treatment will consist of a blinded syringe of 1cc clear liquid 25mg/ml Promethazine
PlaceboPlacebo comparatorDrug: PlaceboThe treatment will consist of a blinded syringe of 1cc 0.9% Sodium Chloride
  • Promethazine (Drug), also known as Phenergan: 1cc 25mg/ml Promethazine (study medication)
  • Placebo (Drug), also known as salt water: 1cc 0.9% Sodium Chloride (placebo)

+Outcome measures

Primary outcomes

  • Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery? [Within first 24 hours after cesarean section]: Pruritus (itching) will be quantified by the ItchyQuant Scale. The ItchyQuant scale is a 0 -10 scale with 0 denoting no itch and 10, the worst itch possible. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their itching. In the results here we reported any itching (a score greater than zero on the ItchyQuant scale) at 24 hours after surgery in each group.

Secondary outcomes

  • Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery? [Within first 24 hours post cesarean section]: Level of consciousness will be quantified by the RASS Scale. The RASS scale is scored with +4 to -5 scale with +4=combative, 0=alert and calm and -5=unrousable. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their level of consciousness. In the results here we reported any score not noted to be 0 (alert and calm) at 24 hours after surgery in each group.
  • Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline? [Within first 24 hours post cesarean section]: We asked patients to rate their sensation of nausea and/or vomiting as none, mild, moderate or severe at 4 time points after cesarean (1 hour, 4 hours and 24 hours after cesarean). Here, we rate any report of nausea and/or vomiting as opposed to no nausea and/or vomiting at 24 hours after cesarean among the patients who had Promethazine and normal saline.

+Eligibility

Sex: Female, ages: 18 Years to 99 Years, accepts healthy volunteers

Inclusion Criteria:

* Pregnant adult female patients of at least 18 years of age consenting to a cesarean birth
* Willing to consent to study.

Exclusion Criteria:

* Male patients
* Incarceration
* Inability to communicate with the investigators
* Allergies to any medications used in the study
* Possessing any contraindication to spinal anesthesia (lack of consent, elevated intracranial pressure, preexisting neurological disease, thrombocytopenia/coagulopathy, hypovolemia, infection at the site of the procedure)
* Patients with an already prolonged QTc (>500 ms)
* Any reason an investigator believes study participation would not be in the best interest of the potential subject.

+Posted results

Participant flow

MilestonePromethazinePlacebo
Started3636
Completed3433
Not completed23

Outcome results

  • Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery? (Primary), Count of participants, Participants: Promethazine 22; Placebo 17
  • Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery? (Secondary), Count of participants, Participants: Promethazine 32; Placebo 31
  • Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline? (Secondary), Count of participants, Participants: Promethazine 31; Placebo 32

Adverse events

Time frame: 24 hours after study drug administration

ArmDeathsSerious adverse eventsOther adverse events
Promethazine0/34 (0.0%)0/34 (0.0%)0/34 (0.0%)
Placebo0/33 (0.0%)0/33 (0.0%)0/33 (0.0%)

Limitations and caveats: We failed to enroll the planned number of patients due to a variety of factors, including challenges in availability of the study drug coupled with slow enrollment. Over two-thirds of the patients who were screened and were able to be contacted prior to surgery declined to participate. This did not support continuing enrollment.

+Locations (1)

FacilityCityCountryStatus
UF Health at the University of FloridaGainesville, FloridaUnited States

+Publications

  • Morgan PJ, Mehta S, Kapala DM. Nalbuphine pretreatment in cesarean section patients receiving epidural morphine. Reg Anesth. 1991 Mar-Apr;16(2):84-8. PMID 2043531
  • Cohen SE, Ratner EF, Kreitzman TR, Archer JH, Mignano LR. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg. 1992 Nov;75(5):747-52. PMID 1416128
  • Vice-O'Con K, Austin PN, Pugh MA. Pharmacologic Methods for Preventing Pruritus in Patients Receiving Intrathecal Opioids for Cesarean Delivery. AANA J. 2018 Feb;86(1):59-66. PMID 31573495
  • Penning JP, Samson B, Baxter AD. Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can J Anaesth. 1988 Nov;35(6):599-604. doi: 10.1007/BF03020347. PMID 3144443
  • Alhashemi JA, Crosby ET, Grodecki W, Duffy PJ, Hull KA, Gallant C. Treatment of intrathecal morphine-induced pruritus following caesarean section. Can J Anaesth. 1997 Oct;44(10):1060-5. doi: 10.1007/BF03019227. PMID 9350364
  • Ituk U, Habib AS. Enhanced recovery after cesarean delivery. F1000Res. 2018 Apr 27;7:F1000 Faculty Rev-513. doi: 10.12688/f1000research.13895.1. eCollection 2018. PMID 29770203
  • Singh PM, Sultan P, O'Carroll J, Blake L, Carvalho B, Singh NP, Monks DT. Pharmacological agents for prevention of pruritus in women undergoing Caesarean delivery with neuraxial morphine: a systematic review and Bayesian network meta-analysis. Br J Anaesth. 2023 Sep;131(3):556-571. doi: 10.1016/j.bja.2023.05.028. Epub 2023 Jul 14. PMID 37455197
  • Moustafa AA, Baaror AS, Abdelazim IA. Comparative study between nalbuphine and ondansetron in prevention of intrathecal morphine-induced pruritus in women undergoing cesarean section. Anesth Essays Res. 2016 May-Aug;10(2):238-44. doi: 10.4103/0259-1162.167839. PMID 27212754
  • Charuluxananan S, Somboonviboon W, Kyokong O, Nimcharoendee K. Ondansetron for treatment of intrathecal morphine-induced pruritus after cesarean delivery. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):535-9. doi: 10.1053/rapm.2000.7809. PMID 11009242
  • Sultan P, Halpern SH, Pushpanathan E, Patel S, Carvalho B. The Effect of Intrathecal Morphine Dose on Outcomes After Elective Cesarean Delivery: A Meta-Analysis. Anesth Analg. 2016 Jul;123(1):154-64. doi: 10.1213/ANE.0000000000001255. PMID 27089000
  • Kumar K, Singh SI. Neuraxial opioid-induced pruritus: An update. J Anaesthesiol Clin Pharmacol. 2013 Jul;29(3):303-7. doi: 10.4103/0970-9185.117045. PMID 24106351
  • Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993 May;168(5):1393-9. doi: 10.1016/s0002-9378(11)90771-6. PMID 8498418
  • Anwari JS, Iqbal S. Antihistamines and potentiation of opioid induced sedation and respiratory depression. Anaesthesia. 2003 May;58(5):494-5. doi: 10.1046/j.1365-2044.2003.03154_18.x. No abstract available. PMID 12694022
  • Results publication: Eldor J, Fishelev V, Levine S, Guedj P, Dudakova I. Prevention of epidural morphine pruritus by intramuscular promethazine in parturients. Reg Anesth. 1994 Nov-Dec;19(6):433-4. No abstract available. PMID 7848959
  • Results publication: Slappendel R, Weber EW, Benraad B, van Limbeek J, Dirksen R. Itching after intrathecal morphine. Incidence and treatment. Eur J Anaesthesiol. 2000 Oct;17(10):616-21. doi: 10.1046/j.1365-2346.2000.00727.x. PMID 11050519
  • Results publication: Horta ML, Morejon LC, da Cruz AW, Dos Santos GR, Welling LC, Terhorst L, Costa RC, Alam RU. Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. Br J Anaesth. 2006 Jun;96(6):796-800. doi: 10.1093/bja/ael072. Epub 2006 Apr 5. PMID 16597655
  • Results publication: Haydek CG, Love E, Mollanazar NK, Valdes Rodriguez R, Lee H, Yosipovitch G, Tharp MD, Hanifin JM, Chen KH, Chen SC. Validation and Banding of the ItchyQuant: A Self-Report Itch Severity Scale. J Invest Dermatol. 2017 Jan;137(1):57-61. doi: 10.1016/j.jid.2016.06.633. Epub 2016 Aug 10. PMID 27521593
  • Results publication: Koju RB, Gurung BS, Dongol Y. Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiol. 2015 Feb 17;15:18. doi: 10.1186/1471-2253-15-18. PMID 25971957

+Study documents

+Investigators